Drug
Probucol clinical trials
Also written Lorelco.
- studies test it
- 19
- open now
- 2
- in phase 3
- 2
- first study started
- 2007
Keep track of what changes. Save the Probucol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
19 studies that test it; most in 2009 (5)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 3
- Phase 3
- 2
- Phase 4
- 11
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 7
Otsuka Beijing Research Institute (7) · Korea Otsuka Pharmaceutical Co., Ltd. (4) · Guangdong Provincial People's Hospital (2) · Asan Medical Center (2) · Seoul National University Hospital (1) · Douglas Mental Health University Institute (1) · General Hospital of Shenyang Military Region (1) · First Affiliated Hospital of Wannan Medical College (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Probucol is read from its arms, and is right about nine times in ten.
Testing it · 19
- The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic PlaquesRecruitingPhase 4General Hospital of Shenyang Military RegionNCT03753555Written as Probucol
- Probucol for Symptomatic Intracranial and Extracranial Artery StenosisRecruitingPhase 3First Affiliated Hospital of Wannan Medical CollegeNCT06225752Written as Probucol
- To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia SubjectCompletedPhase 4Otsuka Beijing Research InstituteNCT02098460Written as Atorvastatin, Probucol, Cilostazol
- Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related BiomarkerCompletedPhase 4Otsuka Beijing Research InstituteNCT00823849Written as Probucol
- Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and SafetyCompletedPhase 2Korea Otsuka Pharmaceutical Co., Ltd.NCT01142284Written as Cilostazol, Probucol
- Pharmacokinetics Study for ProbucolCompletedPhase 4Korea Otsuka Pharmaceutical Co., Ltd.NCT01000467Written as probucol
- Safety and Pharmacokinetics of Probucol and CilostazolCompletedPhase 4Korea Otsuka Pharmaceutical Co., Ltd.NCT00549978Written as Probucol
- Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIseaseCompletedPhase 4Seoul National University HospitalNCT01291641Written as Probucol
- Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive DeteriorationCompletedPhase 1/2Douglas Mental Health University InstituteNCT02707458Written as Probucol
- Efficacy and Safety Study of Probucol in Patients With Diabetic NephropathyCompletedPhase 2Korea Otsuka Pharmaceutical Co., Ltd.NCT01726816Written as Probucol 250mg/day
- Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes NephropathyStatus unknownNot applicableGuangdong Provincial People's HospitalNCT00655330Written as Probucol
- PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT StudyStatus unknownPhase 4Asan Medical CenterNCT02483169Written as Probucol
- PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhageStatus unknownPhase 4Asan Medical CenterNCT01013532Written as Probucol
- A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy VolunteersCompletedNot applicableOtsuka Beijing Research InstituteNCT02196805Written as Group A: imported Probucol ( Lorelco)
- A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA NephropathyCompletedPhase 4Guangdong Provincial People's HospitalNCT00426348Written as Probucol
- Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male SubjectsCompletedPhase 1Otsuka Beijing Research InstituteNCT01590901Written as Probucol
- Efficacy and Safety of Imported Probucol to Treat HyperlipidemiaCompletedPhase 3Otsuka Beijing Research InstituteNCT01349010Written as Probucol
- A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic NephropathyCompletedPhase 4Otsuka Beijing Research InstituteNCT01252056Written as Probucol
- Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study SubjectCompletedPhase 4Otsuka Beijing Research InstituteNCT00823875Written as Probucol group
Codes
What other systems call Probucol · ClinicalTrials.gg INT008091
- MeSH (NLM) D011341ProbucolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) P3CTH044XJPROBUCOLConfirmed FDA, NLM, Wikidata
- RxNorm 8699Confirmed FDA, Wikidata
- Wikidata Q10354103probucolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66470ProbucolOne source FDA
- DrugBank DB01599One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D011341 | Probucol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | P3CTH044XJ | PROBUCOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 8699 | — | Confirmed FDA, Wikidata |
| Wikidata | Q10354103 | probucol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66470 | Probucol | One source FDA |
| DrugBank | DB01599 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.